Financial Instruments
for Research and Innovation
         - HORIZON 2020 -

                                  Martin KOCH

 Policy Officer
                  European Commission - DG Research and Innovation
                         RTD C-03 – Financial Engineering Unit

EU – Israel Seminar on Technology Transfer
                Tel Aviv, 25/26 November 2012




                                                                     Not legally binding
What are EU Financial Instruments?
Equity/risk capital/ loans: e.g. venture capital to SMEs with
high growth potential, risk capital to infrastructure projects and
risk-sharing loans for R&D and innovation investments

Guarantees to financial intermediaries that provide lending to
e.g. infrastructure projects, SMEs, persons at risk of social
exclusion

Other risk-sharing arrangements with financial
intermediaries in order to increase the leverage capacity of the
EU funds (e.g. Project bonds)

or a combination of the above with other forms of EU financial
assistance
                                                                      2
                                                            Not legally binding
EU Financial Instruments: Why
 and when?
Rationale and guiding principles:

1.   Addressing clearly identified funding gaps: Market
     dysfunction due to general economic uncertainty, high
     business/innovation risk (transfer of R&D to innovation and the
     market; innovative SMEs; introduction of new technologies),
     high transaction costs, asymmetric information

2.    Ensuring EU value added:
     • Effective targeting of EU policy goals
     • Catalytic effect on existing similar MS schemes or private
       investment, no crowding out

1.   Leverage effect: Using the EU budget for leveraging additional
     funding through risk-sharing and attraction of private capital
                                                               Not legally binding
HORIZON 2020: Budget proposal for
          Financial Instruments
•HORIZON 2020 budget proposed: EUR 80 billion for the period
2014-2020
•Approximately 4.5% provided not via grants but through
Financial Instruments (various facilities)
•H2020 (SP "Industrial Leadership") – “Access to risk finance”
•€ 3,768 million in current prices (net of administrative costs)
for financial facilities supporting all sizes of companies and types
of entity (demand driven) + additional budget possible for policy
targets (topping-up possibility)

                                                                        4
                                                              Not legally binding
HORIZON 2020: Proposed Financial
         Instruments (FI)
Two Financial Instruments: One for debt, one for
equity
oDebt Financial Instrument: Two facilities
   o Loans and guarantees for investments in Research &
     Innovation (demand-driven; target groups midcaps and
     larger companies, research bodies and stand-alone projects)
   o Guarantee facility for research-intensive and innovative SMEs
     & small midcaps (loan guarantees)
oEquity Financial Instrument – focus on early-stage finance
   o Early stage finance for innovative SMEs and small midcaps
     (seed and start-up companies)
   o Growth-stage finance also possible
   o Implementation in co-operation with the COSME programme
                                                               5
     of the EU (in particular growth-stage)
                                                            Not legally binding
HORIZON 2020 Equity Financial
            Instrument
Provision of early-stage (seed and start-up) finance for
research- and innovation-driven SMEs and small midcaps
through different means:
•Formal VC (Funds-of-Funds; funds)
•Informal VC (Business Angels & their networks)
•Technology Transfer funding ?




                                                               6
                                                     Not legally binding
Technology Transfer funding under
HORIZON 2020: Examination of options
•   Current state-of-play: Concept of TT funding at
    European level under discussion (Commission
    services, JRC, TTOs, EIF)
•   Clarification of added value to address TT funding
    needs at European level (TT funding landscape in
    Europe very divers)
•   Survey of "best practices" and successful models on
    its way (EU Member States and other countries
    including Israel)
•   Budget: No budget foreseen so far in HORIZON
    2020 for dedicated Technology Transfer funding;
    but principal option to include TT funding in the            7
    Equity facility                                    Not legally binding
Technology Transfer funding under
HORIZON 2020: Examination of options
•   Next step: Building the case for a convincing
    justification for TT funding at EU level
•   Key elements in this context:
    •   Addressing a clear funding gap (Proof of concept
        stage, pre-seed and seed phase)
    •   TT funding through equity at various stages
    •   Leverage of EU funding through additional, notably
        private capital
    •   Sustainability, if possible (probably difficult in view of
        the high-risk profile of TT)
    •   Achieving critical mass (no small-scale EU TT fund)
    •   Governance and implementation costs
•   Ex-ante Impact Assessment for TT funding foreseen in
                                                                           8
    early 2013
                                                                 Not legally binding
Thank you very much for your
         attention!




                           Not legally binding
Thank you very much for your
         attention!




                           Not legally binding

Martin koch

  • 1.
    Financial Instruments for Researchand Innovation - HORIZON 2020 - Martin KOCH Policy Officer European Commission - DG Research and Innovation RTD C-03 – Financial Engineering Unit EU – Israel Seminar on Technology Transfer Tel Aviv, 25/26 November 2012 Not legally binding
  • 2.
    What are EUFinancial Instruments? Equity/risk capital/ loans: e.g. venture capital to SMEs with high growth potential, risk capital to infrastructure projects and risk-sharing loans for R&D and innovation investments Guarantees to financial intermediaries that provide lending to e.g. infrastructure projects, SMEs, persons at risk of social exclusion Other risk-sharing arrangements with financial intermediaries in order to increase the leverage capacity of the EU funds (e.g. Project bonds) or a combination of the above with other forms of EU financial assistance 2 Not legally binding
  • 3.
    EU Financial Instruments:Why and when? Rationale and guiding principles: 1. Addressing clearly identified funding gaps: Market dysfunction due to general economic uncertainty, high business/innovation risk (transfer of R&D to innovation and the market; innovative SMEs; introduction of new technologies), high transaction costs, asymmetric information 2. Ensuring EU value added: • Effective targeting of EU policy goals • Catalytic effect on existing similar MS schemes or private investment, no crowding out 1. Leverage effect: Using the EU budget for leveraging additional funding through risk-sharing and attraction of private capital Not legally binding
  • 4.
    HORIZON 2020: Budgetproposal for Financial Instruments •HORIZON 2020 budget proposed: EUR 80 billion for the period 2014-2020 •Approximately 4.5% provided not via grants but through Financial Instruments (various facilities) •H2020 (SP "Industrial Leadership") – “Access to risk finance” •€ 3,768 million in current prices (net of administrative costs) for financial facilities supporting all sizes of companies and types of entity (demand driven) + additional budget possible for policy targets (topping-up possibility) 4 Not legally binding
  • 5.
    HORIZON 2020: ProposedFinancial Instruments (FI) Two Financial Instruments: One for debt, one for equity oDebt Financial Instrument: Two facilities o Loans and guarantees for investments in Research & Innovation (demand-driven; target groups midcaps and larger companies, research bodies and stand-alone projects) o Guarantee facility for research-intensive and innovative SMEs & small midcaps (loan guarantees) oEquity Financial Instrument – focus on early-stage finance o Early stage finance for innovative SMEs and small midcaps (seed and start-up companies) o Growth-stage finance also possible o Implementation in co-operation with the COSME programme 5 of the EU (in particular growth-stage) Not legally binding
  • 6.
    HORIZON 2020 EquityFinancial Instrument Provision of early-stage (seed and start-up) finance for research- and innovation-driven SMEs and small midcaps through different means: •Formal VC (Funds-of-Funds; funds) •Informal VC (Business Angels & their networks) •Technology Transfer funding ? 6 Not legally binding
  • 7.
    Technology Transfer fundingunder HORIZON 2020: Examination of options • Current state-of-play: Concept of TT funding at European level under discussion (Commission services, JRC, TTOs, EIF) • Clarification of added value to address TT funding needs at European level (TT funding landscape in Europe very divers) • Survey of "best practices" and successful models on its way (EU Member States and other countries including Israel) • Budget: No budget foreseen so far in HORIZON 2020 for dedicated Technology Transfer funding; but principal option to include TT funding in the 7 Equity facility Not legally binding
  • 8.
    Technology Transfer fundingunder HORIZON 2020: Examination of options • Next step: Building the case for a convincing justification for TT funding at EU level • Key elements in this context: • Addressing a clear funding gap (Proof of concept stage, pre-seed and seed phase) • TT funding through equity at various stages • Leverage of EU funding through additional, notably private capital • Sustainability, if possible (probably difficult in view of the high-risk profile of TT) • Achieving critical mass (no small-scale EU TT fund) • Governance and implementation costs • Ex-ante Impact Assessment for TT funding foreseen in 8 early 2013 Not legally binding
  • 9.
    Thank you verymuch for your attention! Not legally binding
  • 10.
    Thank you verymuch for your attention! Not legally binding